Concepedia

Publication | Open Access

Systemic PEGylated TRAIL treatment ameliorates liver cirrhosis in rats by eliminating activated hepatic stellate cells

DOIFull Paper Access

80

Citations

17

References

2015

Year

Yumin Oh, Ogyi Park, Magdalena Swierczewska, James P. Hamilton, Jong Sung Park, Tae Hyung Kim, Sung‐Mook Lim, Hana Eom, Dong‐Gyu Jo, Choong‐Eun Lee,
Hepatology

Abstract

TRAIL-based therapies could serve as new therapeutics for liver fibrosis/cirrhosis and possibly other fibrotic diseases. (Hepatology 2016;64:209-223).

References

YearCitations

Page 1